XFW-27769-87223
3 vaccinations
4 coded responses
25 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 431 / OH
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Dose 1 — Moderna
-
2021-01-27
Registered in v-safe
-
2021-01-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
-
2021-02-01
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node in armpit of injection armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — day 7, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node in arm pitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-09
- 2021-02-16
-
2021-02-23
Dose 2 — Moderna
-
2021-03-04
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node in armpit of vaccine armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-04-01
- 2021-04-06
- 2021-05-27
- 2021-08-24
-
2022-10-24
Dose 3 — Pfizer-BioNTech
-
2022-10-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-10-29
- 2022-11-07
- 2022-11-30
- 2022-12-07
- 2023-01-23
-
2023-04-26
Survey response — 6 months, dose 3MedDRA: COVID-19, Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-04-26
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Moderna | |
| 2 | 2021-02-23 | Moderna | |
| 3 | 2022-10-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-26 | Unsuccessful |
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen lymph node in armpit of injection arm
Release 3 — day 7, dose 1
Systemic reaction (other): Swollen lymph node in arm pit
Release 5 — day 7, dose 2
Systemic reaction (other): Swollen lymph node in armpit of vaccine arm
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release